Gastroenterology‎ - Dec 11, 2017 Edition

December 11, 2017     Gastroenterology‎     The latest gastroenterology‎ news from News Medical

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite   A research team at the University of Kent has established the first long-term cultivation system at a laboratory scale for the parasite Cryptosporidium, one of the world's worst and most common causes of diarrhea and death from diarrhea.       Study finds increasing incidence of inflammatory bowel disease in newly industrialized countries   Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialized and westernized, a new study has found.

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers   The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).         Drug improves disease-free, overall survival after hematopoietic stem cell transplants   Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.         Spontaneous humor can be helpful for cancer patients to deal with distress   Analysis led by Lancaster University researchers suggests that spontaneous humor is used and appreciated by people with cancer and can be a helpful way of dealing with distressing, taboo or embarrassing circumstances.

UMSOM researchers find two-way link between TBI and intestinal changes   University of Maryland School of Medicine researchers have found a two-way link between traumatic brain injury (TBI) and intestinal changes. These interactions may contribute to increased infections in these patients, and may also worsen chronic brain damage.       Scientists identify new strategies used by Helicobacter pylori to target mitochondria   Helicobacter pylori is a bacterial pathogen that colonizes the stomach of approximately half of the world's population. Infection with H. pylori is acquired in childhood and lasts for decades.       Study identifies new role for stress receptor CRF1 expressed on mast cells   A new study published online in the Journal of Leukocyte Biology provides new insight into how stress, through signaling of corticotropin-releasing factor (CRF), interacts with cells in the immune system to cause disease.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK